EASL Clinical Practice Guidelines

Disclosures

Antonio Craxi has received research support, lecture fees and took part in clinical trials for Roche, MSD, Siemens, and Abbott. Geoffrey Dusheiko has received research support, lecture fees and took part in clinical trials for Vertex, Gilead, Novartis, Novartis Genome Sciences, Pharmasett, Roche, MSD, Tibotec, Abbott, Boehringer Ingelheim, BMS, and Pfizer. Robert Flisiak has received research support, lecture fees from Roche, MSD, BMS, Novartis, Debiopharm, Pfizer, and Gilead. Xavier Forns has received research support and took part in clinical trials for Roche and Schering-Plough/MSD, and Janssen. Markus Peck-Radosavljevic has received research support, lecture fees from MSD, and Roche. Jean-Michel Pawlotsky has received research support, lecture fees and took part in clinical trials for Abbott, Achillion, Anadys, Biotica, Boehringer-Ingelheim, Bristol-Myers Squibb, DebioPharm, Gilead, Glaxo-SmithKline, Idenix, Janssen-Cilag/Tibotec, Madaus Rottapharm, Merck/Schering-Plough, Novartis, Pfizer, Pharmasset, Roche, and Vertex. William Rosenberg has received research support, lecture fees and took part in clinical trials Roche, Gilead, MSD, Boehringer-Inghelheim, Siemens. He is a stockholder of iQUR LTD. Christoph Sarrazin has received research support, lecture fees and took part in clinical trials for Roche, MSD, Siemens, and Abbott. Heiner Wedemeyer has received research support, lecture fees and took part in clinical trials for Roche, MSD, Novartis, Gilead, BMS, Abbott, Biolex, and Johnson & Johnson. Ira Jacobson has received research support, lecture fees and took part in clinical trials for MSD, Novartis, Gilead, BMS, Abbott, Vertex, Tibotec, Pfizer, Pharmasset, Boehringer-Inghelheim, GlobeImmune, Anadys, Zymogenetics, Sanofi-aventis, Glaxo-SmithKline, Achillion, Biolex, Human Genome Sciences, and Roche/Genentech. He is on a speaker's bureau for MSD, Gilead, MSD, Roche/Genentech.